Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services. Our strong commitment of improving health and well-being of the people is supported by in-depth industry knowledge, well-qualified team of professionals, as well as hi-tech and advanced infrastructure which enables us to provide highly potent and cytotoxic anti-tumor Active Pharmaceutical Ingredients (APIs) to our customers globally. With years of unremitting efforts, we have emerged as one of the fastest growing organizations in the pharmaceutical industry, as we believe a step forward brings us closer to our commitment to the people.
Year Established: 2016
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 100-500
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production Capacity,Large Product Line,Contract Manufacturing (CRO,CMO),Buyers' Specifications Accepted,Small Orders Accepted,Quality Service
Business Type: Manufacturer
R&D Capacity: OEM,ODM,Own Brand
Annual Turnover(USD) : 500,000 to 99,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia
Subscribe to the latest newsletter of Virtual Expo Connect
SO-PNP
PO-PNP
MIP-PNP
ER-PNP